Abstract
OBJECTIVE: Digital vasculopathy (comprising RP, digital ulceration and critical digital ischaemia) is responsible for much of the pain and disability experienced by patients with SSc. However, there is a limited evidence base to guide clinicians in the management of SSc-related digital vasculopathy. Our aim was to produce recommendations that would be helpful for clinicians, especially for those managing patients outside specialist centres. METHODS: The UK Systemic Sclerosis Study Group set up several working groups to develop a number of consensus best practice pathways for the management of SSc-specific complications, including digital vasculopathy. RESULTS: This overview presents the background and best practice consensus pathways for SSc-related RP, digital ulceration and critical ischaemia. Examples of drug therapies, including doses, are suggested in order to inform prescribing practice. CONCLUSION: A number of treatment algorithms are provided that are intended to provide the clinician with accessible reference tools for use in daily management.
Original language | English |
---|---|
Pages (from-to) | 2015-2024 |
Number of pages | 9 |
Journal | Rheumatology (Oxford, England) |
Volume | 54 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- Raynaud’s phenomenon
- critical digital ischaemia
- digital ulcer
- digital vasculopathy
- scleroderma
- systemic sclerosis